This study evaluated the effectiveness and safety of percutaneous sclerotherapy for maxillofacial venous malformations.
Patients who had venous malformations involving the masticatory muscles and who underwent sclerotherapy were enrolled in this retrospective study.
Twenty-four patients (13 female, 11 male; mean age 21 years) were analyzed. Major clinical symptoms were swelling (100%) and intralesional pain (54%). Intramuscular lesions involved the masseter muscle only in 38% of cases, both the masseter and temporalis muscles in 33%, all masticatory muscles in 21%, and the temporalis muscle only in 8%. Extramuscular involvement was observed in 58% of patients. Absolute ethanol and polidocanol were used as sclerosants. The mean number of sclerotherapy sessions per patient was 6.6 (range, 1-32). The mean follow-up duration after the first sclerotherapy session was 64.8 months (range, 6-178). The complications included paralysis of the facial nerve (25%), intraoral ulceration (8%), and hemoglobinuria (8%). The effectiveness of treatment was rated as excellent in 33% of cases, good in 46%, and fair in 21%. Better results were obtained in patients without extramuscular involvement.
Percutaneous sclerotherapy can be effective and safe for maxillofacial intramuscular venous malformations, especially for localized lesions of the masseter muscle.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Sclerotherapy of craniofacial venous malformations: complications and results.Plast Reconstr Surg. 1999; 104: 1-11
- Craniofacial venous malformations: magnetic resonance imaging features that predict treatment outcome.J Oral Maxillofac Surg. 2009; 67: 2388-2396
- Venous malformations of skeletal muscle.Plast Reconstr Surg. 2002; 110: 1625-1635
- Sclerotherapy of oral and facial venous malformations with use of pingyangmycin and/or sodium morrhuate.Int J Oral Maxillofac Surg. 2004; 33: 463-466
- The role of imaging and surgery in the management of vascular tumors of the masseter muscle.J Oral Maxillofac Surg. 2005; 63: 1746-1752
- Intramuscular vascular malformation of the masseter muscle presenting with turkey wattle sign. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 102: 618-624
- Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.J Oral Maxillofac Surg. 2010; 68: 2258-2266
- Masseteric venous malformations: diagnosis, treatment, and outcomes.Otolaryngol Head Neck Surg. 2010; 143: 779-783
- Biological classification of soft-tissue vascular anomalies: MR correlation.AJR Am J Roentgenol. 1991; 157: 559-564
- Preliminary experience with a new sclerosing foam in the treatment of varicose veins.Dermatol Surg. 2001; 27: 58-60
- Marked acute tissue swelling following percutaneous sclerosis of low-flow vascular malformations: a predictor of both prolonged recovery and therapeutic effect.Pediatr Radiol. 2000; 30: 415-419
- Long-term results and quality of life after endovascular treatment of venous malformations in the face and neck.Acta Radiol. 2004; 45: 738-745
- Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents.J Plast Reconstr Aesthet Surg. 2016; 69: 295-304
- Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.J Vasc Surg. 2003; 37: 533-538
- Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation.Head Neck. 2011; 33: 1616-1621
- Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients.Arch Dermatol. 2008; 144: 861-867
- Venous malformation: update on aetiopathogenesis, diagnosis and management.Phlebology. 2010; 25: 224-235
- Venous malformation associated nerve profiles and pain: an immunohistochemical study.J Plast Reconstr Aesthet Surg. 2011; 64: 439-444
Published online: July 29, 2022
Accepted: July 21, 2022
Received in revised form: July 14, 2022
Received: June 13, 2022
© 2022 Published by Elsevier Inc.